Friday - In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with a steady price target of $105.00.

RBC Capital Markets also lifted its price target to $116, citing Boston Scientific's strong initial guide for 2025 and solid execution as key drivers. Truist Securities echoed these sentiments ...

In a report released on February 26, Nik Modi from RBC Capital maintained a Hold rating on Boston Beer (SAM – Research Report), with a price ...

RBC Capital lowered the firm’s price target on Boston Beer (SAM) to $295 from $318 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q4 results across ...